Dystrophy Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Dystrophy stocks.

Dystrophy Stocks Recent News

Date Stock Title
May 28 SRPT RBC Capital cuts Sarepta to sector perform ahead of FDA decision
May 28 BMY ASPIRE: Our Commitment To Address Health Inequities in Low- and Middle-Income Countries
May 28 PTCT PTC Therapeutics announces validation of Sepiapterin European MAA
May 28 PTCT PTC Therapeutics Announces Validation of Sepiapterin European MAA
May 28 IONS Ionis to hold donidalorsen Phase 3 data webcast
May 26 FULC Goldman Sachs Predicts up to 108% Rally for These 2 ‘Strong Buy’ Stocks
May 25 BMY Viking, CRISPR, Intellia among potential M&A targets: Wells Fargo
May 25 PTCT Insider Sale: Director Jerome Zeldis Sells 20,000 Shares of PTC Therapeutics Inc (PTCT)
May 24 SRPT Implied Volatility Surging for Sarepta (SRPT) Stock Options
May 24 PTCT The Zacks Analyst Blog Highlights Biogen, Ionis Pharmaceuticals, GSK, PTC Therapeutics and Larimar Therapeutics
May 24 IONS The Zacks Analyst Blog Highlights Biogen, Ionis Pharmaceuticals, GSK, PTC Therapeutics and Larimar Therapeutics
May 24 BMY Terran Biosciences prepares for trials of schizophrenia drug
May 23 BMY Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel Modalities and Research Platforms
May 23 PTCT Biotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News
May 23 BMY Bristol Myers Squibb: 5.5% Yielder Has Been Crushed In What Could Be A Generational Buying Opportunity
May 23 BMY Does Bristol-Myers Squibb (NYSE:BMY) Have A Healthy Balance Sheet?
May 23 BMY This Unpopular Dividend Stock Is a Buy
May 23 IONS New data from the Phase 3 NEURO-TTRansform study evaluating WAINUA™ (eplontersen) to be presented at the 2024 International Symposium on Amyloidosis (ISA)
May 23 BMY Bristol Myers Squibb to Present Data at the 2024 American Society of Clinical Psychopharmacology Annual Meeting
May 22 BMY Bristol-Myers Squibb snaps six days of losses, trades in the green
Dystrophy

Dystrophy is the degeneration of tissue, due to disease or malnutrition, most likely due to heredity.

Browse All Tags